Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth J Heathcote

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Current Opinion in Gastroenterology|April 28, 2009
Cholestasis and cholestatic syndromesGideon M Hirschfield, Elizabeth J Heathcote
Hepatology (Baltimore, Md.)|July 27, 2002
Resistance surveillance in chronic hepatitis B patients treated with adefovir dipivoxil for up to 60 weeksHuiling Yang, Christopher E Westland, William E Delaney, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 22, 2008
Gene expression profiling of early primary biliary cirrhosis: possible insights into the mechanism of action of ursodeoxycholic acidLimin Chen, Ivan Borozan, Piotr Milkiewicz, et al.
Journal of Hepatology|July 10, 2010
The novel immunoregulatory molecule FGL2: a potential biomarker for severity of chronic hepatitis C virus infectionKatharina Foerster, Ahmed Helmy, Yi Zhu, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Current Opinion in Gastroenterology|April 28, 2009
Cholestasis and cholestatic syndromesGideon M Hirschfield, Elizabeth J Heathcote
Hepatology (Baltimore, Md.)|July 27, 2002
Resistance surveillance in chronic hepatitis B patients treated with adefovir dipivoxil for up to 60 weeksHuiling Yang, Christopher E Westland, William E Delaney, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 22, 2008
Gene expression profiling of early primary biliary cirrhosis: possible insights into the mechanism of action of ursodeoxycholic acidLimin Chen, Ivan Borozan, Piotr Milkiewicz, et al.
Journal of Hepatology|July 10, 2010
The novel immunoregulatory molecule FGL2: a potential biomarker for severity of chronic hepatitis C virus infectionKatharina Foerster, Ahmed Helmy, Yi Zhu, et al.
Pageof 1